Target intelligence / Profile preview

Integrin subunit alpha 6 (ITGA6)

Target
ITGA6
Molecular classification
Receptor, Integrin family
01

Overview

Integrin subunit alpha 6 is a cell-surface protein encoded by the ITGA6 gene. It functions as part of two major heterodimeric integrin receptors: alpha-6/beta-4, which is critical for the structural stability of epithelia and forms hemidesmosomes anchoring the epidermis, and alpha-6/beta-1, implicated in developmental tissue morphogenesis[1][2][4][6][7]. Both heterodimers act as receptors for laminins, mediating cell-matrix adhesion, signal transduction, and regulation of cell proliferation, survival, and migration[1][4][6][7]. Alterations in integrin alpha-6 expression or function are linked to several pathological states, including carcinoma progression and rare genetic skin disorders, underscoring its dual importance in tissue integrity and as a potential therapeutic target[2][4][5].

Other names
Integrin alpha-6CD49fVLA-6 (when heterodimerized with beta-1)TSP180 (when heterodimerized with beta-4)ITGA6 gene product
02

Mechanism of action

Inhibition of cell adhesion and migration by blocking the interaction between integrin alpha-6 and its ligands (e.g., laminins) Disruption of signaling pathways involved in metastasis and proliferation (preclinical research)

03

Biological functions

Cell adhesionCell-surface mediated signalingSignal transductionCell proliferationMaintenance of tissue integrityRegulation of cell cycle
04

Disease associations

Cancer (e.g., carcinomas, breast cancer, prostate cancer)Epidermolysis bullosa with pyloric atresiaInflammation (through barrier dysfunction and repair)Other epithelial disorders
05

Safety considerations

Risk of impaired wound healing and tissue integrity when targeted due to its key role in epithelial attachmentPotential risk of skin fragility or blistering, as evidenced by genetic deficiency (e.g., epidermolysis bullosa with pyloric atresia)On-target effects may cause epithelial or mucosal barrier disturbances
06

Biomarkers

Integrin alpha-6 (CD49f) expression is used as a biomarker for basal-like or stem-like cancer cells, such as in breast and prostate cancerMarker for epithelial stem cells

Beyond the preview

Go deeper on Integrin subunit alpha 6 (ITGA6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integrin subunit alpha 6 (ITGA6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call